MetaCap

SeaStar Medical (ICU) vs Intelligent Bio Solutions (INBS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

SeaStar Medical is the larger company by market cap ($5.0 million vs $4.6 million), about 1.1 times the size. Intelligent Bio Solutions converts more of its revenue into profit, with a net margin of -294.9% versus -984.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ICU-74.87%INBS-12.58%
+50%-17%-85%
Oct 7, 20261 yearNov 20, 2026
ICU-74.10%INBS-9.15%
+34%-24%-82%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ICU versus INBS key metrics
MetricICUINBS
Share price$0.935$1.39
Market cap$4.97M$4.61M
1-day change-10.95%-7.95%
YTD return-61.04%—
1-year return-69.34%—
5-year return-99.96%—
Forward P/E—3.97
EPS (TTM)$-2.71$-6.38
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$1.23M$4.22M
Revenue growth (YoY)+814.07%+38.09%
Net income (latest FY)$-12.15M$-12.43M
Gross margin95.71%48.63%
Operating margin-986.63%-299.11%
Net margin-984.60%-294.91%
52-week high$5.38$24.90
52-week low$0.761$1.35
Distance from 52-week high-82.62%-94.42%
Analyst consensusnonenone
Avg. price target upside+969.52%+763.31%
Average volume196.27K129.01K
Shares outstanding5.32M3.32M
Employees1859
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Intelligent Bio Solutions is more profitable, keeping -294.9 cents of every revenue dollar as net income versus -984.6 cents for SeaStar Medical.
  • SeaStar Medical grew revenue faster in its latest fiscal year (+814.07% vs +38.09%).

About SeaStar Medical

ICU stock →

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis.

Health Care · Medical/Dental Instruments · 18 employees

About Intelligent Bio Solutions

INBS stock →

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform.

Health Care · Medical/Dental Instruments · 59 employees

ICU vs INBS FAQ

Which is bigger, SeaStar Medical or Intelligent Bio Solutions?

SeaStar Medical (ICU) is larger, with a market capitalization of $4.97M compared with $4.61M for Intelligent Bio Solutions (INBS).

Are SeaStar Medical and Intelligent Bio Solutions in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons